| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.05 |